tm logo
RAYVOW
REGISTERED

on 16 Apr 2020

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1896352 filed on 30th Apr 2018

Registration Number

TMA1076907 registered on 16th Apr 2020

Registration expiry Date

16th Apr 2030

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

RAYVOW

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, anxiety disorders, atopic dermatiti Read More

Classification Information


Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.


Classification kind code

11

Mark Details


Serial Number

1896352

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 24th May 2019
Allowed
Submitted for opposition 51
on 24th May 2019
Allowance Notice Sent
Submitted for opposition 42
on 06th Feb 2019
Advertised
Submitted for opposition 26
on 17th Jan 2019
Approved
Submitted for opposition 27
on 26th Nov 2018
Approval Notice Sent
Submitted for opposition 22
on 16th Jul 2018
Search Recorded
Submitted for opposition 20
on 16th Jul 2018
Examiner's First Report
Submitted for opposition 31
on 01st May 2018
Formalized
Submitted for opposition 30
on 30th Apr 2018
Filed
Submitted for opposition 1
on 30th Apr 2018
Created